4//SEC Filing
Frenkel Ran 4
Accession 0001209191-22-008128
CIK 0001503802other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:26 PM ET
Size
5.5 KB
Accession
0001209191-22-008128
Insider Transaction Report
Form 4
Frenkel Ran
EVP, WW Development Operations
Transactions
- Sale
Common Stock
2022-02-07$9.86/sh−1,991$19,635→ 104,632 total
Footnotes (3)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.
- [F3]Includes 861 shares and 1,323 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 30, 2021 and October 31, 2021, respectively.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001623108
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:26 PM ET
- Size
- 5.5 KB